INM
InMed Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$1.75
+4.17%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 9.29x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.01x
- Price / sales
- 0.00x
- Price / cash flow
- -0.01x
Enterprise value
- Enterprise value
- -$1.1B
- EV / sales
- -0.55x
- EV / EBITDA
- 112.25x
- EV / EBIT
- 102.77x
- Market cap
- $9.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026